Private equity group acquires stem cell company

Friday 2 October 2009

The Riverside Company, a private equity group with offices in Brussels, Belgium, has acquired Crioestaminal SA of Portugal which collects stem cells from umbilical cord blood.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Portugal